SAFETY, PHARMACOKINETICS, AND CLINICAL EFFICACY OF ADS051, A NEUTROPHIL MODULATOR, IN ULCERATIVE COLITIS: RESULTS OF A RANDOMIZED PHASE 1B TRIAL.
Allegretti JR, Cheifetz AS, Dulai PS, Stevens AC, Chapas-Reed J, Chesnel L, Dixit B, Farquhar R, Ghahramani P, Miller BW, Murphy CK, Quintas M, Tanase R, Telia T, Woźniak-Stolarska B, Gupta R.
Allegretti JR, et al. Among authors: murphy ck.
Am J Gastroenterol. 2024 Dec 31. doi: 10.14309/ajg.0000000000003269. Online ahead of print.
Am J Gastroenterol. 2024.
PMID: 39787364